Switch to:
More From Other Websites
12:51 pm Sanofi initiates the ICARIA-MM Phase III trial of isatuximab after preseting prelim results... Dec 05 2016
Sanofi Genzyme Announces Start of Phase III Study of Isatuximab for Relapsed and Refractory Multiple... Dec 05 2016
Blog Coverage MyoKardia Announced Receipt of Payment from Sanofi Dec 05 2016
Sanofi and JHL Biotech Announce Strategic Biologics Alliance in China Dec 04 2016
Drugs Delayed By Regeneron, Sanofi Plant (REGN, SNY) Dec 01 2016
Mymetics Starts Research Project with Sanofi for Influenza Vaccines Dec 01 2016
Sanofi SA (ADR) (SNY) Facing Manufacturing Headache On Two Blockbusters Nov 30 2016
NVIDIA, Sotheby's Holdings, Celgene, Regeneron Pharmaceuticals and Sanofi highlighted as Zacks Bull... Nov 30 2016
The Zacks Analyst Blog Highlights: UnitedHealth, 21st Century Fox, Sanofi, MasterCard and Barclays Nov 30 2016
Sanofi Partnership Passes First Test With Delivery of Antibiotic Compounds Nov 30 2016
Novo's New Insulin Reduces Risk of Low Blood Sugar, Study Shows Nov 29 2016
Johnson & Johnson Reportedly Hikes Bid For Swiss Drugmaker Actelion Nov 29 2016
Warren Buffett's Only Dividend Stocks With 4%-Plus Yields Nov 29 2016
Top Research Reports for 29th November, 2016 Nov 29 2016
Sanofi Receives Antibiotic Compounds From Partnership Nov 29 2016
Amicus Tumbles on Lengthy Delay to U.S. Fabry Drug FDA Filing Plan Nov 28 2016
Actelion's ambitious independent-minded CEO will drive up takeover price Nov 28 2016
Actelion's ambitious independent-minded CEO will drive up takeover price Nov 28 2016
Johnson & Johnson Confirms Takeover Talks With Actelion Pharmaceuticals Nov 25 2016
Here is What Hedge Funds Think about Gilead Sciences, Inc. (GILD) Nov 24 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK